Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
GLARGL07667Transition IIEudraCT: 2015-002416-33Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
GLARGL07699OPTIMIZEEudraCT: 2015-001186-46Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
GLARGL07710COBALTAEudraCT: 2015-004715-20Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
GLARGL07921EASENCT02954692Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
GLARGL08200TOP1NCT03406000Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
LPS13931REACH CONTROLEudraCT: 2015-001831-18Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
LPS14060REACH CONTROLEudraCT: 2015-001832-39Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
LPS14347ACHIEVE CONTROL REAL LIFE STUDY PROGRAMNCT02451137Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
LPS14409TAKE ControlEudraCT: 2015-001626-42Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
LPS14584BRIGHTEudraCT: 2015-005101-36Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted